Peter Scully
Impact in
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
- Oncology 6
- Cancer-related Molecular Pathways 5
-
- Ocular Oncology and Treatments 5
- Co-authors
- Wen‐Hwa Lee (3 shared papers)Jin‐Yuh Shew (2 shared papers)Phang‐Lang Chen (2 shared papers)Robert Bookstein (2 shared papers)Jean Y. J. Wang (1 shared paper)Eva Y.-H.P. Lee (1 shared paper)Jin-Yuh Shew (1 shared paper)J Cheng (2 shared papers)
- Journals
- Blood (2 papers)Science (2 papers)The Laryngoscope (1 paper)Cell (1 paper)PubMed (1 paper)
- Partner nations
- United StatesBelarusCzechia
In The Last Decade
Peter Scully
8 papers receiving 2.0k citations
Peter Scully's Hit Papers
Peers
Comparison fields: 5 of 84
- Ophthalmology 594
- Oncology 1.4k
- Cancer Research 271
- Molecular Biology 1.1k
- Genetics 444
Countries citing papers authored by Peter Scully
This map shows the geographic impact of Peter Scully's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Scully with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Scully more than expected).
Fields of papers citing papers by Peter Scully
This network shows the impact of papers produced by Peter Scully. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Scully. The network helps show where Peter Scully may publish in the future.
Co-authors
The 24 scholars most cited alongside Peter Scully, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation Hit paper breakdown → | 1989 | 895 |
| 2 | Inactivation of the Retinoblastoma Susceptibility Gene in Human Breast Cancers Hit paper breakdown → | 1988 | 541 |
| 3 | Suppression of Tumorigenicity of Human Prostate Carcinoma Cells by Replacing a Mutated RB Gene Hit paper breakdown → | 1990 | 541 |
| 4 | 1990 | 64 | |
| 5 | AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. | 1988 | 41 |
| 6 | 1982 | 22 | |
| 7 | 1990 | 7 | |
| 8 | 2007 | 2 |
About Peter Scully
Peter Scully is a scholar working on Oncology, Ophthalmology, Genetics, Immunology and Molecular Biology, having authored 8 papers that have together received 2.1k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (5 papers), Cancer-related Molecular Pathways (5 papers), interferon and immune responses (2 papers), Virus-based gene therapy research (2 papers), Nanoplatforms for cancer theranostics (1 paper), Head and Neck Cancer Studies (1 paper), Laser-Ablation Synthesis of Nanoparticles (1 paper) and Tracheal and airway disorders (1 paper). The work is most often cited by research in Ophthalmology (594 citations), Oncology (1.4k citations), Cancer Research (271 citations), Molecular Biology (1.1k citations) and Genetics (444 citations). Peter Scully has collaborated with scholars based in United States, Belarus and Czechia. Frequent co-authors include Wen‐Hwa Lee, Jin‐Yuh Shew, Phang‐Lang Chen, Robert Bookstein, Jean Y. J. Wang, Eva Y.-H.P. Lee, Jin-Yuh Shew, J Cheng, Martin Haas and Lee Wh. Their work appears in journals such as Blood, Science, The Laryngoscope, Cell and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.